NorthStar Medical Radioisotopes, LLC

Beloit,  WI 
United States
https://www.northstarnm.com/
  • Booth: 237


Our Mission: Providing Patients Global Access to Game-Changing Radiopharmaeuticals

NorthStar Medical Radioisotopes is a commercial-stage radiopharmaceutical company at the forefront of advancing patient care by utilizing novel technologies to produce commercial-scale radioisotopes that, once attached to a molecule, have the ability to detect and treat cancer and other serious diseases. NorthStar’s expanding industry-leading position in the emerging field of radiopharmaceutical therapy is supported by its unique capabilities in the sophisticated production of radioisotopes, proven management team, and state-of-the-art, environmentally preferable technologies. NorthStar routinely produces copper-67 (Cu-67) and is poised to be one of the first commercial-scale producers of non-carrier-added (n.c.a.) actinium-225 (Ac-225). The Company’s Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) services unit provides customized service offerings and specialized radiopharmaceutical expertise to help biopharmaceutical companies rapidly advance their development and commercial programs. For more information about NorthStar’s comprehensive portfolio and patient-focused services, visit: www.northstarnm.com.

 Products

  • Copper-67 (Cu-67)
    Copper-67 (Cu-67) is a short-range, beta-emitting radioisotope which is attractive for medical purposes due to its ability to carry sufficient radiation energy to cause cell death in targeted cells while having a short half-life, limiting radioactivity in otherwise healthy tissue....

  • n.c.a. Actinium-225 (Ac-225)
    Actinium-225 (Ac-225) is considered one of the rarest radioisotopes on earth.  It is not naturally occurring and therefore needs to be manufactured. There are several technologies used to produce Ac-225 but none that can scale to meet commercial quantities.
    NorthStar's method is capable of meeting customer demand. ...

  • CDMO/CMO
    Our comprehensive services support collaborator companies by providing solutions to help navigate the complex radiopharmaceutical development and manufacturing process. NorthStar's Radiopharmaceutical CDMO/CMO services span the spectrum of radioisotope drug development, from research and scale-up through commercialization, and all are designed to meet rigorous clinical trial and patient use requirements.  Our proven expertise in innovation, engineering, manufacturing, quality assurance and quality control, adherence to regulatory standards, and logistics are applied to meet each customer's specific needs....

Categories

All
  • Radioisotopes
  • Radiopharmaceuticals
  • Services
    • Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Appointment Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined